Purchase Order HHSF223201300278P

<p>The Food and Drug Administration issued a purchase order to Bioivt, LLC on July 30, 2026, for metabolism-qualified cryopreserved human hepatocytes, with a ceiling value of $33,510.10 and a firm fixed price. Performance occurs in Silver Spring, Maryland, with ultimate completion by January 29, 2027. No set-aside applied to this commercial acquisition.</p>

This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...

The Defense Health Agency awarded a $19,320 firm fixed-price delivery order to Bioivt, LLC for cryoplateable hepatocytes. The contract, awarded on August 11, 2025, with an ultimate completion date of September 30, 2025, represents a non-competitive delivery order issued under an existing indefinite delivery vehicle. Bioivt, headquartered in Westbury, New York, will perform all work at its primary facility location. No set-aside designation was utilized for this procurement, indicating the...

This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Life Technologies Corporation for the delivery of 50 vials of human spheroid-qualified hepatocytes. As described in the original solicitation, these liver cells will support the National Institute on Drug Abuse's Antiviral Program for Pandemics by enabling the continued identification of direct-acting antivirals and development of microphysiological systems...

The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...

This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...

Xenotech LLC, doing business as Sekisui-Xenotech, has been awarded a firm fixed price purchase order totaling twenty-five thousand three hundred thirty-three dollars by the Environmental Protection Agency Office of Research and Development. Under this contract, Xenotech will deliver twenty-one vials of cryopreserved human hepatocytes to support the agency's research and development programs. As a self-certified small disadvantaged business, Xenotech specializes in drug metabolism and drug-drug...

This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Bioivt, LLC, a provider of biological specimens and services. The contract is for the delivery of 5 million units of male human cryoplateable hepatocytes, with a ceiling value of $75,000.00 and a period of performance ending on July 30, 2021. Bioivt has previously provided biological materials and services as a prime contractor and subcontractor to...

<p>The Department of the Army Medical Command awarded a $105,000 firm fixed price delivery order to Bioivt, LLC of Westbury, New York on July 7, 2021. The order calls for the delivery of monkey cryoplateable hepatocytes by July 13, 2021. No set-aside designation was used for this contract. Bioivt will provide the hepatocytes to support research at the Army Medical Command. As the prime contractor, Bioivt will be solely responsible for fulfilling the delivery order requirements.</p>

This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to BioIVT, LLC for the procurement of various Hepatopac sample well plates, including human, mouse, and stromal plates, as well as maintenance and application media. The total ceiling value of the contract is $27,249.00, with an anticipated 60-day delivery after receipt of order. The purchase order was awarded on a...